Candriam Luxembourg S.C.A. »

Cardiff Oncology shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Cardiff Oncology (CRDF) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Cardiff Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cardiff Oncology held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiff Oncology by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2025-12-31 $968k 344k 2.81

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Mastercard Incorporated Cl A (MA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Gilead Sciences (GILD)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Cardiff Oncology

BlackRock
Vanguard Group
Laurion Capital Management
Pfizer
William Blair $ Company
Acorn Capital Advisors
Geode Capital Management
Franklin Resources
State Street Corporation
Putnam Fl Investment Management
Northern Trust
Goldman Sachs Group
Candriam Luxembourg S.C.A.
Bank of New York Mellon
Susquehanna International

View all funds holding Cardiff Oncology